Skip to content
healthcare.dev
Get a free key

MAX Tussin Mucus and Chest Congestion

NDC 71399-0054, Guaifenesin, liquid, from Akron Pharma Inc..

Product NDC
71399-0054
Status
Listed
Labeler
Akron Pharma Inc.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71399-0054 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN200 mg/10mL

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
71399-0054-4713990054041 BOTTLE in 1 PACKAGE (71399-0054-4) / 118 mL in 1 BOTTLE
71399-0054-671399005406473 mL in 1 BOTTLE (71399-0054-6)
71399-0054-8713990054081 BOTTLE in 1 PACKAGE (71399-0054-8) / 236 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 71399-0054 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71399-0054 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71399-0054. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.